SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
1.370
+0.070 (5.38%)
Apr 23, 2025, 4:00 PM EDT - Market closed
SAB Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.